The weekly litigation news digest is live. Subscribe now

IP Verse

Animal Models And Therapeutic Molecules - EP3241435

The patent EP3241435 was granted to Kymab on May 26, 2021. The application was filed on Jul 7, 2010 under application number EP17174426A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3241435

KYMAB
Application Number
EP17174426A
Filing Date
Jul 7, 2010
Status
Granted And Under Opposition
Apr 23, 2021
Publication Date
May 26, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
REGENERON PHARMACEUTICALSFeb 25, 2022J A KEMPWITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO02066630
OPPOSITIONWO2009076464
OPPOSITIONWO2010039900
SEARCHUS2006015957
SEARCHWO02066630
SEARCHWO2007117410

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents